Drug profile

The FDA adverse-event record for Docp

138 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Docp. See the species affected, top reactions, and outcomes below.

138
adverse-event reports
6.5%
death-coded share
Dog
most-reported species
41
Immediate pain upon injection - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
138
Total Reports
9
Deaths Reported
6.5%
Death Rate

Active Ingredients

Docp

Administration Routes

UnknownIntramuscularSubcutaneousIntravenousOtherParenteral

Species Affected

Dog 136
Cat 1
Goat 1

Most Affected Breeds

Retriever - Labrador 15
Poodle - Standard 9
Retriever - Golden 7
Crossbred Canine/dog 6
Chihuahua 5
Dog (unknown) 5
Pointing Dog - German Short-haired 5
Maltese 5
Shepherd Dog - German 5
Terrier (unspecified) 4

Most Reported Reactions

Immediate pain upon injection 41
High sodium-potassium ratio (Na:K ratio) 29
Vomiting 23
Diarrhoea 19
Lethargy (see also Central nervous system depression in 'Neurological') 17
Polyuria 15
Weight loss 11
Polydipsia 11
Elevated blood urea nitrogen (BUN) 10
Hyponatremia 8
Decreased appetite 8
Hypochloraemia 8

Outcome Breakdown

Recovered/Normal
63 (45.7%)
Outcome Unknown
51 (37.0%)
Ongoing
14 (10.1%)
Died
5 (3.6%)
Euthanized
4 (2.9%)
Recovered with Sequela
1 (0.7%)

Docp Adverse Event Insights

138 reports name Docp; 9 recorded a death outcome (6.5% of reported events, not a population-level mortality rate). Active ingredient: Docp. Administration routes: Unknown, Intramuscular, Subcutaneous, Intravenous.

By species: Dog (136 reports), Cat (1 reports), Goat (1 reports). By breed: Retriever - Labrador (15), Poodle - Standard (9), Retriever - Golden (7).

Leading clinical signs: Immediate pain upon injection (41), High sodium-potassium ratio (Na:K ratio) (29), Vomiting (23), Diarrhoea (19). Outcome, 138 coded reports: Recovered/Normal leads at 45.7%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.